Evidence map›Paper›PMID 29611009›Full record

ArticleNanoscale research letters2018

Development of Electrospun Chitosan-Polyethylene Oxide/Fibrinogen Biocomposite for Potential Wound Healing Applications.

Tony T Yuan, Ann Marie DiGeorge Foushee, Monica C Johnson, Angela R Jockheck-Clark, Jonathan M Stahl

Abstract read
In one paragraph

Article in Nanoscale research letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Towards sustainable antimicrobial therapies forSustainable microbiology · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tony T YuanNaval Medical Research Unit San Antonio, 3650 Chambers Pass, Bldg 3610 BHT-2, JBSA Fort Sam Houston, TX, 78234-6315, USA.
Ann Marie DiGeorge FousheeNaval Medical Research Unit San Antonio, 3650 Chambers Pass, Bldg 3610 BHT-2, JBSA Fort Sam Houston, TX, 78234-6315, USA.
Monica C JohnsonNaval Medical Research Unit San Antonio, 3650 Chambers Pass, Bldg 3610 BHT-2, JBSA Fort Sam Houston, TX, 78234-6315, USA.
Angela R Jockheck-ClarkNaval Medical Research Unit San Antonio, 3650 Chambers Pass, Bldg 3610 BHT-2, JBSA Fort Sam Houston, TX, 78234-6315, USA.
Jonathan M StahlNaval Medical Research Unit San Antonio, 3650 Chambers Pass, Bldg 3610 BHT-2, JBSA Fort Sam Houston, TX, 78234-6315, USA. jonathan.m.stahl.mil@mail.mil.

Funding

Naval Medical Research Center's Advanced Medical Development Program G1406
6 · The paper itself

Abstract

Normal wound healing is a highly complex process that requires the interplay of various growth factors and cell types. Despite advancements in biomaterials, only a few bioactive wound dressings reach the clinical setting. The purpose of this research was to explore the feasibility of electrospinning a novel nanofibrous chitosan (CS)-fibrinogen (Fb) scaffold capable of sustained release of platelet-derived growth factor (PDGF) for the promotion of fibroblast migration and wound healing. CS-Fb scaffolds were successfully electrospun using a dual-spinneret electrospinner and directly evaluated for their physical, chemical, and biological characteristics. CS-polyethylene/Fb scaffolds exhibited thinner fiber diameters than nanofibers electrospun from the individual components while demonstrating adequate mechanical properties and homogeneous polymer distribution. In addition, the scaffold demonstrated acceptable water transfer rates for wound healing applications. PDGF was successfully incorporated in the scaffold and maintained functional activity throughout the electrospinning process. Furthermore, released PDGF was effective at promoting fibroblast migration equivalent to a single 50 ng/mL dose of PDGF. The current study demonstrates that PDGF-loaded CS-Fb nanofibrous scaffolds possess characteristics that would be highly beneficial as novel bioactive dressings for enhancement of wound healing.

Indexed as

Biomedical applicationsChitosanElectrospinningFibrinogenNanofibersPDGFWound dressingWound healing

Identifiers

PMID29611009
PMCPMC5880797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.